Resultados de la búsqueda 461-470 of 10610 for prostate cancer

  1. Oncología (médica) - Ensayos clínicos

    This study aims to identify candidate High Grade Serous Cancer (HGSC) early detection and chemotherapy treatment response biomarkers.

  2. Cirugía - Ensayos clínicos - Mayo Clinic

    ... carcinoma (Arm 1) or to primary colorectal carcinoma (Arm 2), based on treatment-related adverse events reported by National Cancer Institute (NCI) Common ...

  3. Cirugía - Ensayos clínicos - Mayo Clinic

    The primary purpose of this study is to examine the effects of abemaciclib on the CD8/FOXP3 ratio in chemotherapy-resistant triple negative breast cancer (TNBC) ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to see if different depths of submucosal tumor invasion in esophageal cancer can predict lymph node involvement and survival. A ...

  5. Cirugía - Ensayos clínicos - Mayo Clinic

    The main objective of the Brain Tumor Repository is to allow access to coded patient data by researchers both inside and outside of the Mayo Clinic system so ...

  6. Cirugía - Ensayos clínicos - Mayo Clinic

    ... cancer over time. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Borderline Resectable Pancreatic Cancer - Tumor-vessel interface ≥180° of vessel wall circumference, and/or reconstructible occlusion of the SMV-PV.

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Using radiation techniques, such as intensity modulated radiotherapy to avoid ...

  9. Tratamiento oncológico - Mayo Clinic

    ... cáncer es curar tu cáncer ... https://www.cancer.net/navigating-cancer-care/cancer-basics/cancer-terms. ... Mayo Clinic Minute: Improvements in prostate surgery ...

  10. Cirugía - Ensayos clínicos - Mayo Clinic

    ... cancer, and to evaluate whether the baseline peripheral blood immune phenotype differs between patients with breast cancer and age-matched healthy controls.